Headache menstrual

Emergency contraceptives The most common adverse events in the clinical trial for women receiving emergency contraceptives include nausea abdominal pain/cramps fatigue headache menstrual irregularities dizziness breast tenderness vomiting diarrhea. 

Flatulence, loss of appetite, nausea, colic, headache, menstrual problems, skin irritation... 

Nonnarcotic analgesics treat mild to moderate pain such as headaches, menstrual pain (dysmenorrheal), inflammatory pain, muscular aches, and abrasions. Nonnarcotic analgesics include acetaminophen and NS AIDs (see chapter 12). Nonnarcotic analgesics are not addictive and available over the counter. 

Naproxen 220 mg every 12 hours as needed for headaches and menstrual pain... 

Evaluate the patient for symptoms, such as headache, visual disturbances, menstrual cycles in women, and sexual function in men, to assess clinical response to therapy. 

First trimester Menstrual spotting, missed menses, fatigue, breast tenderness, increased urination, mood swings, nau-sea/vomiting, headache, heartburn, constipation Second trimester Frequent urination, heartburn, constipation, dry skin, edema, linea nigra, melasma Third trimester Backache, edema, shortness of breath Routine Pregnancy Visits... 

Side effects of contraceptives tend to occur in the first few months of therapy. Thus, schedule a follow-up visit 3 to 6 months after initiating a new contraceptive. Yearly checkups usually are sufficient for patients who are doing well on a particular product.1 At each follow-up visit, assess blood pressure, headache frequency, and menstrual bleeding patterns, as well as compliance with the prescribed regimen. 

Patients with secondary hypertension may complain of symptoms suggestive of the underlying disorder. Patients with pheochromocytoma may have a history of paroxysmal headaches, sweating, tachycardia, palpitations, and orthostatic hypotension. In primary aldosteronism, hypokalemic symptoms of muscle cramps and weakness may be present. Patients with hypertension secondary to Cushing s syndrome may complain of weight gain, polyuria, edema, menstrual irregularities, recurrent acne, or muscular weakness. 

The major adverse effect is irregular menstrual bleeding. Other side effects are headache, vaginitis, weight gain, acne, and breast and abdominal pain. It does not appear to decrease BMD. It is contraindicated in women who are pregnant, have active liver disease, a history of thromboembolic events, or a history of breast cancer. 

Preventive therapy may also be administered intermittently when headaches recur in a predictable pattern (e.g., exercise-induced or menstrual migraine). 

Common (at least 3%) adverse reactions include menstrual irregularities weight changes headache nervousness abdominal pain discomfort asthenia dizziness. 

Fluticasone - Adverse reactions occurring in 3% or more of patients include headache pharyngitis nasal congestion sinusitis rhinitis upper respiratory tract infection influenza oral candidiasis diarrhea dysphonia menstrual disturbance nasal discharge allergic rhinitis fever. 

Miscellaneous Anxiety depression dizziness headache rash abdominal pain/discomfort gingival disorder infectious diarrhea nausea rectal pain/discomfort tooth disorder vomiting arthritis back pain myalgia lower extremity pain menstrual irregularity vaginitis influenza upper/lower respiratory tract infection fatigue otitis sleep disorder urinary tract infection. 

Excessive dosage produces signs and symptoms of hyperthyroidism, including weight loss, palpitations, increased appetite, tremors, nervousness, tachycardia, hypertension, headache, insomnia, and menstrual irregularities,... 

The common side effects are drowsiness, lethargy, ataxia. They also cause behavioural changes and dose dependent impairment of visual motor coordination. Other side effects which occur rarely are vertigo, headache, allergy, photosensitization, leucopenia, impaired sexual function and menstrual irregularities. 

Side effects include headache, fatigue, drowsiness, nausea, tachycardia, palpitations, dry mouth, GIT disturbances, taste disturbances, photosensitivity, dysmenor-rhoea and menstrual disorders. 

Results from a clinical trial of cabergoline in women with hyperprolactinemia and anovulation. A The dotted line indicates the upper limit of normal serum prolactin concentrations. B Complete success was defined as pregnancy or at least two consecutive menses with evidence of ovulation at least once. Partial success was two menstrual cycles without evidence of ovulation or just one ovulatory cycle. The most common reasons for withdrawal from the trial were nausea, headache, dizziness, abdominal pain, and fatigue. 

Spironolactone as a diuretic is discussed in Chapter 15. The drug has benefits in heart failure greater than those predicted from its diuretic effects alone (see Chapter 13). Adverse effects reported for spironolactone include hyperkalemia, cardiac arrhythmia, menstrual abnormalities, gynecomastia, sedation, headache, gastrointestinal disturbances, and skin rashes. 

---